ESC Premium Access

Impact of atrial fibrillation on soluble fms-like tyrosine kinase-1 and cardiovascular events in patients with suspected or known coronary artery disease: The EXCEED-J Study

Congress Presentation

About the speaker

Doctor Hiromichi Wada

Kyoto Medical Centre, Kyoto (Japan)
0 follower

205 more presentations in this session

Optimal timing of intervention in NSTE-ACS without pre-treatment

Speaker: Doctor I. Almeida (Barreiro, PT)

Thumbnail

Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome

Speaker: Doctor I. Almeida (Barreiro, PT)

Thumbnail

Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Thumbnail

Clinical outcomes by angiographic type of spontaneous coronary artery dissection

Speaker: Doctor R. Mori Junco (Madrid, ES)

Thumbnail

Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome

Speaker: Doctor Y. Minematsu (Saga, JP)

Thumbnail

Access the full session

Acute Coronary Syndromes ePosters

Speakers: Doctor H. Wada, Doctor I. Almeida, Doctor I. Almeida, Associate Professor D. Maximkin, Doctor R. Mori Junco...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Diagnosis of CCS: from the clinical likelihood to the assessment of event risk.

29 August 2021

ESC Premium Access

Heart failure phenotype, comorbidity and obstructive sleep apnoea.

29 August 2021

ESC Premium Access

Obstructive sleep apnoea (OSA): what the cardiologist must know - Chat Moderator.

29 August 2021

ESC 365 is supported by

logo Novo Nordisk